{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T22:50:14Z","timestamp":1780959014762,"version":"3.54.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T00:00:00Z","timestamp":1650240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T00:00:00Z","timestamp":1650240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100016568","name":"Nippon Zoki Pharmaceutical","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016568","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s40261-022-01139-5","type":"journal-article","created":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T08:02:40Z","timestamp":1650268960000},"page":"403-416","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Efficacy and Safety of Tramadol Hydrochloride Twice-Daily Sustained-Release Bilayer Tablets with an Immediate-Release Component for Chronic Pain Associated with Knee Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled, Treatment-Withdrawal Study"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3996-0039","authenticated-orcid":false,"given":"Shinichi","family":"Kawai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Sobajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Jinnouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideshi","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Ohtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mineo","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,18]]},"reference":[{"issue":"9991","key":"1139_CR1","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/s0140-6736(14)60802-3","volume":"386","author":"S Glyn-Jones","year":"2015","unstructured":"Glyn-Jones S, Palmer AJ, Agricola R, et al. Osteoarthritis. Lancet. 2015;386(9991):376\u201387. https:\/\/doi.org\/10.1016\/s0140-6736(14)60802-3.","journal-title":"Lancet"},{"issue":"3","key":"1139_CR2","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.joca.2018.11.001","volume":"27","author":"LA Mandl","year":"2019","unstructured":"Mandl LA. Osteoarthritis year in review 2018: clinical. Osteoarthritis Cartilage. 2019;27(3):359\u201364. https:\/\/doi.org\/10.1016\/j.joca.2018.11.001.","journal-title":"Osteoarthritis Cartilage"},{"issue":"4","key":"1139_CR3","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jbspin.2017.08.002","volume":"85","author":"AP Trouvin","year":"2018","unstructured":"Trouvin AP, Perrot S. Pain in osteoarthritis. Implications for optimal management. Joint Bone Spine. 2018;85(4):429\u201334. https:\/\/doi.org\/10.1016\/j.jbspin.2017.08.002.","journal-title":"Joint Bone Spine"},{"issue":"1","key":"1139_CR4","doi-asserted-by":"publisher","first-page":"99","DOI":"10.20344\/amp.5477","volume":"28","author":"D Pereira","year":"2015","unstructured":"Pereira D, Ramos E, Branco J. Osteoarthritis. Acta Med Port. 2015;28(1):99\u2013106. https:\/\/doi.org\/10.20344\/amp.5477.","journal-title":"Acta Med Port"},{"issue":"3","key":"1139_CR5","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s40520-020-01762-2","volume":"33","author":"KM Leyland","year":"2021","unstructured":"Leyland KM, Gates LS, Sanchez-Santos MT, et al. Knee osteoarthritis and time-to all-cause mortality in six community-based cohorts: an international meta-analysis of individual participant-level data. Aging Clin Exp Res. 2021;33(3):529\u201345. https:\/\/doi.org\/10.1007\/s40520-020-01762-2.","journal-title":"Aging Clin Exp Res"},{"issue":"2","key":"1139_CR6","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/acr.24131","volume":"72","author":"SL Kolasinski","year":"2020","unstructured":"Kolasinski SL, Neogi T, Hochberg MC, et al. 2019 American College of Rheumatology\/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2020;72(2):149\u201362. https:\/\/doi.org\/10.1002\/acr.24131.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"1139_CR7","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s40520-021-01834-x","volume":"33","author":"SS Yeap","year":"2021","unstructured":"Yeap SS, Tanavalee A, Perez EC, et al. 2019 revised algorithm for the management of knee osteoarthritis: the Southeast Asian viewpoint. Aging Clin Exp Res. 2021;33(5):1149\u201356. https:\/\/doi.org\/10.1007\/s40520-021-01834-x.","journal-title":"Aging Clin Exp Res"},{"issue":"8","key":"1139_CR8","first-page":"523","volume":"97","author":"MH Ebell","year":"2018","unstructured":"Ebell MH. Osteoarthritis: rapid evidence review. Am Fam Physician. 2018;97(8):523\u20136.","journal-title":"Am Fam Physician"},{"issue":"6","key":"1139_CR9","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1001\/jama.2020.22171","volume":"325","author":"JN Katz","year":"2021","unstructured":"Katz JN, Arant KR, Loeser RF. Diagnosis and treatment of hip and knee osteoarthritis: a review. JAMA. 2021;325(6):568\u201378. https:\/\/doi.org\/10.1001\/jama.2020.22171.","journal-title":"JAMA"},{"issue":"6","key":"1139_CR10","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.amjopharm.2012.09.004","volume":"10","author":"CK O'Neil","year":"2012","unstructured":"O\u2019Neil CK, Hanlon JT, Marcum ZA. Adverse effects of analgesics commonly used by older adults with osteoarthritis: focus on non-opioid and opioid analgesics. Am J Geriatr Pharmacother. 2012;10(6):331\u201342. https:\/\/doi.org\/10.1016\/j.amjopharm.2012.09.004.","journal-title":"Am J Geriatr Pharmacother"},{"issue":"3","key":"1139_CR11","doi-asserted-by":"publisher","first-page":"230949901880866","DOI":"10.1177\/2309499018808669","volume":"26","author":"O Aweid","year":"2018","unstructured":"Aweid O, Haider Z, Saed A, Kalairajah Y. Treatment modalities for hip and knee osteoarthritis: a systematic review of safety. J Orthop Surg (Hong Kong). 2018;26(3):2309499018808669. https:\/\/doi.org\/10.1177\/2309499018808669.","journal-title":"J Orthop Surg (Hong Kong)"},{"key":"1139_CR12","doi-asserted-by":"publisher","first-page":"320","DOI":"10.2174\/1874312901206010320","volume":"6","author":"M van Laar","year":"2012","unstructured":"van Laar M, Pergolizzi JV Jr, Mellinghoff HU, et al. Pain treatment in arthritis-related pain: beyond NSAIDs. Open Rheumatol J. 2012;6:320\u201330. https:\/\/doi.org\/10.2174\/1874312901206010320.","journal-title":"Open Rheumatol J."},{"key":"1139_CR13","doi-asserted-by":"publisher","first-page":"17002","DOI":"10.1038\/nrdp.2017.2","volume":"3","author":"L Colloca","year":"2017","unstructured":"Colloca L, Ludman T, Bouhassira D, et al. Neuropathic pain. Nat Rev Dis Primers. 2017;3:17002. https:\/\/doi.org\/10.1038\/nrdp.2017.2.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"1139_CR14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jpainsymman.2003.11.006","volume":"28","author":"N Babul","year":"2004","unstructured":"Babul N, Noveck R, Chipman H, Roth SH, Gana T, Albert K. Efficacy and safety of extended-release, once-daily tramadol in chronic pain: a randomized 12-week clinical trial in osteoarthritis of the knee. J Pain Symptom Manage. 2004;28(1):59\u201371. https:\/\/doi.org\/10.1016\/j.jpainsymman.2003.11.006.","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"1139_CR15","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1097\/MJT.0b013e3181cec307","volume":"18","author":"BP DeLemos","year":"2011","unstructured":"DeLemos BP, Xiang J, Benson C, et al. Tramadol hydrochloride extended-release once-daily in the treatment of osteoarthritis of the knee and\/or hip: a double-blind, randomized, dose-ranging trial. Am J Ther. 2011;18(3):216\u201326. https:\/\/doi.org\/10.1097\/MJT.0b013e3181cec307.","journal-title":"Am J Ther"},{"issue":"5","key":"1139_CR16","doi-asserted-by":"publisher","first-page":"273","DOI":"10.5055\/jom.2007.0015","volume":"3","author":"RL Fishman","year":"2007","unstructured":"Fishman RL, Kistler CJ, Ellerbusch MT, et al. Efficacy and safety of 12 weeks of osteoarthritic pain therapy with once-daily tramadol (Tramadol Contramid OAD). J Opioid Manag. 2007;3(5):273\u201380. https:\/\/doi.org\/10.5055\/jom.2007.0015.","journal-title":"J Opioid Manag"},{"issue":"7","key":"1139_CR17","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1185\/030079906x115595","volume":"22","author":"TJ Gana","year":"2006","unstructured":"Gana TJ, Pascual ML, Fleming RR, et al. Extended-release tramadol in the treatment of osteoarthritis: a multicenter, randomized, double-blind, placebo-controlled clinical trial. Curr Med Res Opin. 2006;22(7):1391\u2013401. https:\/\/doi.org\/10.1185\/030079906x115595.","journal-title":"Curr Med Res Opin"},{"issue":"11","key":"1139_CR18","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1016\/j.clinthera.2004.11.005","volume":"26","author":"H Malonne","year":"2004","unstructured":"Malonne H, Coffiner M, Sonet B, Sereno A, Vanderbist F. Efficacy and tolerability of sustained-release tramadol in the treatment of symptomatic osteoarthritis of the hip or knee: a multicenter, randomized, double-blind, placebo-controlled study. Clin Ther. 2004;26(11):1774\u201382. https:\/\/doi.org\/10.1016\/j.clinthera.2004.11.005.","journal-title":"Clin Ther"},{"issue":"3","key":"1139_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2165\/00044011-199714030-00001","volume":"1997","author":"J Sorge","year":"1997","unstructured":"Sorge J, Stadler T. Comparison of the analgesic efficacy and tolerability of tramadol 100\u00a0mg sustained-release tablets and tramadol 50 mg capsules for the treatment of chronic low back pain. Clin Drug Investig. 1997;1997(3):157\u201364.","journal-title":"Clin Drug Investig"},{"issue":"2","key":"1139_CR20","doi-asserted-by":"publisher","first-page":"87","DOI":"10.5055\/jom.2008.0013","volume":"4","author":"GJ Vorsanger","year":"2008","unstructured":"Vorsanger GJ, Xiang J, Gana TJ, Pascual ML, Fleming RR. Extended-release tramadol (tramadol ER) in the treatment of chronic low back pain. J Opioid Manag. 2008;4(2):87\u201397. https:\/\/doi.org\/10.5055\/jom.2008.0013.","journal-title":"J Opioid Manag"},{"issue":"5","key":"1139_CR21","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1185\/03007995.2012.681035","volume":"28","author":"B Lasko","year":"2012","unstructured":"Lasko B, Levitt RJ, Rainsford KD, Bouchard S, Rozova A, Robertson S. Extended-release tramadol\/paracetamol in moderate-to-severe pain: a randomized, placebo-controlled study in patients with acute low back pain. Curr Med Res Opin. 2012;28(5):847\u201357. https:\/\/doi.org\/10.1185\/03007995.2012.681035.","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"1139_CR22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1185\/03007995.2014.975338","volume":"31","author":"YB Park","year":"2015","unstructured":"Park YB, Ha CW, Cho SD, et al. A randomized study to compare the efficacy and safety of extended-release and immediate-release tramadol HCl\/acetaminophen in patients with acute pain following total knee replacement. Curr Med Res Opin. 2015;31(1):75\u201384. https:\/\/doi.org\/10.1185\/03007995.2014.975338.","journal-title":"Curr Med Res Opin"},{"issue":"11","key":"1139_CR23","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1517\/14656566.2011.576250","volume":"12","author":"JV Pergolizzi Jr","year":"2011","unstructured":"Pergolizzi JV Jr, Taylor R Jr, Raffa RB. Extended-release formulations of tramadol in the treatment of chronic pain. Expert Opin Pharmacother. 2011;12(11):1757\u201368. https:\/\/doi.org\/10.1517\/14656566.2011.576250.","journal-title":"Expert Opin Pharmacother"},{"issue":"2","key":"1139_CR24","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/MJT.0b013e31815b035b","volume":"15","author":"RL Barkin","year":"2008","unstructured":"Barkin RL. Extended-release Tramadol (ULTRAM ER): a pharmacotherapeutic, pharmacokinetic, and pharmacodynamic focus on effectiveness and safety in patients with chronic\/persistent pain. Am J Ther. 2008;15(2):157\u201366. https:\/\/doi.org\/10.1097\/MJT.0b013e31815b035b.","journal-title":"Am J Ther"},{"key":"1139_CR25","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2147\/jpr.S49502","volume":"7","author":"A Kizilbash","year":"2014","unstructured":"Kizilbash A, Ng\u00f4-Minh CT. Review of extended-release formulations of Tramadol for the management of chronic non-cancer pain: focus on marketed formulations. J Pain Res. 2014;7:149\u201361. https:\/\/doi.org\/10.2147\/jpr.S49502.","journal-title":"J Pain Res"},{"key":"1139_CR26","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/245346","volume":"2013","author":"C Angeletti","year":"2013","unstructured":"Angeletti C, Guetti C, Paladini A, Varrassi G. Tramadol extended-release for the management of pain due to osteoarthritis. ISRN Pain. 2013;2013:245346. https:\/\/doi.org\/10.1155\/2013\/245346.","journal-title":"ISRN Pain"},{"issue":"12","key":"1139_CR27","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1586\/14737175.7.12.1775","volume":"7","author":"G Mongin","year":"2007","unstructured":"Mongin G. Tramadol extended-release formulations in the management of pain due to osteoarthritis. Expert Rev Neurother. 2007;7(12):1775\u201384. https:\/\/doi.org\/10.1586\/14737175.7.12.1775.","journal-title":"Expert Rev Neurother"},{"key":"1139_CR28","unstructured":"Twotram\u00ae (tramadol) tablets, 50 mg, 100 mg, 150 mg; Nippon Zoki Pharmaceutical Co., Ltd. Interview Form, January 2021 (4th Edition). Available at: https:\/\/www.info.pmda.go.jp\/go\/interview\/1\/530288_1149038G2026_1_060_1F.pdf. Accessed 14 May 2021. (In Japanese)"},{"issue":"8","key":"1139_CR29","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1002\/art.1780290816","volume":"29","author":"R Altman","year":"1986","unstructured":"Altman R, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum. 1986;29(8):1039\u201349. https:\/\/doi.org\/10.1002\/art.1780290816.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"1139_CR30","first-page":"1524","volume":"32","author":"M Akai","year":"2005","unstructured":"Akai M, Doi T, Fujino K, Iwaya T, Kurosawa H, Nasu T. An outcome measure for Japanese people with knee osteoarthritis. J Rheumatol. 2005;32(8):1524\u201332.","journal-title":"J Rheumatol"},{"issue":"1","key":"1139_CR31","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00776-014-0645-9","volume":"20","author":"T Sugita","year":"2015","unstructured":"Sugita T, Kikuchi Y, Aizawa T, Sasaki A, Miyatake N, Maeda I. Quality of life after bilateral total knee arthroplasty determined by a 3-year longitudinal evaluation using the Japanese knee osteoarthritis measure. J Orthop Sci. 2015;20(1):137\u201342. https:\/\/doi.org\/10.1007\/s00776-014-0645-9.","journal-title":"J Orthop Sci"},{"issue":"2","key":"1139_CR32","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/s0304-3959(01)00349-9","volume":"94","author":"JT Farrar","year":"2001","unstructured":"Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole MR. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001;94(2):149\u201358. https:\/\/doi.org\/10.1016\/s0304-3959(01)00349-9.","journal-title":"Pain"},{"issue":"1","key":"1139_CR33","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1185\/03007990903426787","volume":"26","author":"PC Langley","year":"2010","unstructured":"Langley PC, Patkar AD, Boswell KA, Benson CJ, Schein JR. Adverse event profile of tramadol in recent clinical studies of chronic osteoarthritis pain. Curr Med Res Opin. 2010;26(1):239\u201351. https:\/\/doi.org\/10.1185\/03007990903426787.","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"1139_CR34","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.jpainsymman.2006.11.017","volume":"34","author":"F Burch","year":"2007","unstructured":"Burch F, Fishman R, Messina N, et al. A comparison of the analgesic efficacy of Tramadol Contramid OAD versus placebo in patients with pain due to osteoarthritis. J Pain Symptom Manage. 2007;34(3):328\u201338. https:\/\/doi.org\/10.1016\/j.jpainsymman.2006.11.017.","journal-title":"J Pain Symptom Manage"},{"issue":"11","key":"1139_CR35","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1517\/14656566.9.11.1817","volume":"9","author":"OG Florete","year":"2008","unstructured":"Florete OG, Xiang J, Vorsanger GJ. Effects of extended-release tramadol on pain-related sleep parameters in patients with osteoarthritis. Expert Opin Pharmacother. 2008;9(11):1817\u201327. https:\/\/doi.org\/10.1517\/14656566.9.11.1817.","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"1139_CR36","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2165\/00044011-200525010-00003","volume":"25","author":"I Tagarro","year":"2005","unstructured":"Tagarro I, Herrera J, Barutell C, et al. Effect of a simple dose-escalation schedule on tramadol tolerability: assessment in the clinical setting. Clin Drug Investig. 2005;25(1):23\u201331. https:\/\/doi.org\/10.2165\/00044011-200525010-00003.","journal-title":"Clin Drug Investig"},{"issue":"6","key":"1139_CR37","doi-asserted-by":"publisher","first-page":"415","DOI":"10.2165\/00044011-199917060-00001","volume":"17","author":"M Raber","year":"1999","unstructured":"Raber M, Hofmann S, Junge K, Momberger H, Kuhn D. Analgesic efficacy and tolerability of Tramadol 100\u00a0mg sustained-release capsules in patients with moderate to severe chronic low back pain. Clin Drug Investig. 1999;17(6):415\u201323. https:\/\/doi.org\/10.2165\/00044011-199917060-00001.","journal-title":"Clin Drug Investig"},{"issue":"5","key":"1139_CR38","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/bcp.12275","volume":"77","author":"B Vrijens","year":"2014","unstructured":"Vrijens B, Claeys MJ, Legrand V, Vandendriessche E, Van de Werf F. Projected inhibition of platelet aggregation with ticagrelor twice daily vs. clopidogrel once daily based on patient adherence data (the TWICE project). Br J Clin Pharmacol. 2014;77(5):746\u201355. https:\/\/doi.org\/10.1111\/bcp.12275.","journal-title":"Br J Clin Pharmacol"},{"issue":"9","key":"1139_CR39","doi-asserted-by":"publisher","first-page":"765","DOI":"10.2165\/00023210-200721090-00005","volume":"21","author":"M Bialer","year":"2007","unstructured":"Bialer M. Extended-release formulations for the treatment of epilepsy. CNS Drugs. 2007;21(9):765\u201374. https:\/\/doi.org\/10.2165\/00023210-200721090-00005.","journal-title":"CNS Drugs"},{"issue":"7","key":"1139_CR40","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1086\/651118","volume":"50","author":"C Flexner","year":"2010","unstructured":"Flexner C, Tierney C, Gross R, et al. Comparison of once-daily versus twice-daily combination antiretroviral therapy in treatment-naive patients: results of AIDS clinical trials group (ACTG) A5073, a 48-week randomized controlled trial. Clin Infect Dis. 2010;50(7):1041\u201352. https:\/\/doi.org\/10.1086\/651118.","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-022-01139-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40261-022-01139-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-022-01139-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T03:36:12Z","timestamp":1652499372000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40261-022-01139-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,18]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["1139"],"URL":"https:\/\/doi.org\/10.1007\/s40261-022-01139-5","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,18]]},"assertion":[{"value":"6 March 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was funded by Nippon Zoki Pharmaceutical Co., Ltd.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Shinichi Kawai, Satoshi Sobajima, and Masashi Jinnouchi have\u00a0received research grants from Nippon Zoki Pharmaceutical Co., Ltd. Hideshi Nakano, Hideaki Ohtani, Mineo Sakata, and Takeshi Adachi are employees of Nippon Zoki Pharmaceutical Co., Ltd.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the institutional review boards at all 24 participating institutions.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All patients provided written informed consent. The following investigators gave consent to be named in this report: Atsuyoshi Samura (Hanazono Orthopedic Internal Medicine, Saitama), Akira Kobayashi (Kobayashi Orthopedics, Saitama), Michio Inoue (Inoue Orthopedics, Saitama), Hisayuki Izaki (Otakibashi Orthopedics, Tokyo), Shinichi Yamaguchi (Gonohashi Clinic, Tokyo), Masahiro Ishii (Sakaue Orthopedic Plastic Clinic, Tokyo), Masashi Jinnouchi (Nishi Waseda Orthopedic Surgery, Tokyo), Hisayuki Miyajima (Meguro Yuai Clinic, Tokyo), Masayo Kato (Ando Orthopedics, Kanagawa), Hiroaki Shibata (Shibata Orthopedics, Kanagawa), Shinichi Katsuo (Fukui General Hospital, Fukui), Katsunori Mizuno (Fukui General Clinic, Fukui), Kiyoshi Miura (Kanai Hospital, Kyoto), Satoshi Sobajima (SOBAJIMA Clinic, Osaka), Shinichi Yamaguchi (Yamaguchi Clinic, Osaka), Takehiro Nishimura (Suita Municipal Hospital, Osaka).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The datasets generated during and\/or analyzed during the current study are available from the corresponding author on reasonable request.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Materials"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"Data curation: M. Sakata, T. Adachi. Formal analysis: T. Adachi. Investigation: S. Sobajima, M. Jinnouchi. Methodology: S. Kawai, H. Ohtani, M. Sakata, T. Adachi. Project administration: H. Ohtani. Resources: S. Sobajima, M. Jinnouchi. Supervision: S. Kawai, H. Nakano, H. Ohtani. Visualization: H. Ohtani. Writing \u2013 original draft: S. Kawai, H. Nakano, H. Ohtani, M. Sakata, T. Adachi. Writing \u2013 review and editing: all authors.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 Contributions"}}]}}